We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $299M | 7.91% |
1,466,300
-1,375,700
| -48% | -$283M |
|
|
2
PUT
Biogen
BIIB
$29.9B
| $164M | 4.34% |
535,000
+351,500
| +192% | +$101M |
|
|
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $157M | 4.16% |
771,800
+158,800
| +26% | +$32.6M |
|
|
4
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $93.7M | 2.48% |
459,576
+66,541
| +17% | +$13.7M |
|
5
PUT
Invesco QQQ Trust
QQQ
$455B
| $65.6M | 1.74% |
586,500
-639,900
| -52% | -$71.4M |
|
|
AGN
6
PUT
DELISTED
Allergan plc
AGN
| $59.4M | 1.57% |
+190,000
| New | +$56.6M |
|
|
7
Biogen
BIIB
$29.9B
| $44.7M | 1.18% |
146,050
+72,517
| +99% | +$20.8M |
|
|
8
CALL
Biogen
BIIB
$29.9B
| $37.9M | 1% |
123,800
+31,100
| +34% | +$8.94M |
|
|
EMC
9
PUT
DELISTED
EMC CORPORATION
EMC
| $32.2M | 0.85% |
+1,252,000
| New | +$32.5M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $30.1M | 0.8% |
+96,344
| New | +$28.7M |
|
11
PUT
iShares Russell 2000 ETF
IWM
$80.9B
| $27.8M | 0.74% |
247,000
-1,217,900
| -83% | -$140M |
|
12
CALL
iShares Silver Trust
SLV
$28.1B
| $27.1M | 0.72% |
2,053,000
| – | – |
|
13
CALL
Gilead Sciences
GILD
$161B
| $26.9M | 0.71% |
265,600
+128,100
| +93% | +$13.3M |
|
|
14
Invesco CurrencyShares Euro Currency Trust
FXE
$331M
| $22.9M | 0.61% |
+215,696
| New | +$23.2M |
|
15
PUT
Amazon
AMZN
$2.5T
| $22M | 0.58% |
652,000
+488,000
| +298% | +$15.4M |
|
|
TWC
16
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $20.6M | 0.55% |
111,050
-10,343
| -9% | -$1.92M |
|
17
CALL
SPDR Gold Trust
GLD
$131B
| $20.5M | 0.54% |
202,000
-1,008,000
| -83% | -$107M |
|
|
18
IBM
IBM
$202B
| $19.4M | 0.51% |
147,496
+128,112
| +661% | +$17.2M |
|
|
EMC
19
DELISTED
EMC CORPORATION
EMC
| $19.3M | 0.51% |
750,000
+613,146
| +448% | +$15.9M |
|
|
20
Invesco QQQ Trust
QQQ
$455B
| $19.2M | 0.51% |
171,450
+122,467
| +250% | +$13.7M |
|
|
21
iShares Russell 2000 ETF
IWM
$80.9B
| $18.2M | 0.48% |
162,023
+115,437
| +248% | +$13.3M |
|
|
GMCR
22
CALL
DELISTED
KEURIG GREEN MTN INC
GMCR
| $18M | 0.48% |
+200,000
| New | +$12.4M |
|
|
23
Nike
NKE
$61.9B
| $18M | 0.48% |
287,651
+284,283
| +8,441% | +$18.3M |
|
|
VXX
24
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $17.8M | 0.47% |
55,356
-12,350
| -18% | -$3.93M |
|
25
PUT
iShares MSCI Emerging Markets ETF
EEM
$28B
| $17.7M | 0.47% |
550,000
-115,000
| -17% | -$3.94M |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
BWP
MC
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.